These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 454917)

  • 1. The relationship between cholinergic and dopaminergic mechanisms in the nucleus accumbens for the control of locomotor activity [proceedings].
    Costall B; Hui SC; Naylor RJ
    Br J Pharmacol; 1979 May; 66(1):121P-122P. PubMed ID: 454917
    [No Abstract]   [Full Text] [Related]  

  • 2. Modulation by dopaminergic and serotonergic systems of cholinergic interneurons in nucleus accumbens and striatum.
    Bluth R; Langnickel R; Ott T
    Pol J Pharmacol Pharm; 1985; 37(6):753-63. PubMed ID: 3832017
    [TBL] [Abstract][Full Text] [Related]  

  • 3. On the structural requirements for dopamine-like activity in homogenates of rat nucleus accumbens [proceedings].
    Munday KA; Poat JA; Watling KJ; Woodruff GN
    Br J Pharmacol; 1977 Sep; 61(1):150P-151P. PubMed ID: 912199
    [No Abstract]   [Full Text] [Related]  

  • 4. GABA-dopamine interaction in substantia nigra and nucleus accumbens--relevance to behavioral stimulation and stereotyped behavior.
    Scheel-Krüger J; Arnt J; Braestrup C; Christensen AV; Cools AR; Magelund G
    Adv Biochem Psychopharmacol; 1978; 19():343-6. PubMed ID: 567933
    [No Abstract]   [Full Text] [Related]  

  • 5. Pharmacological manipulations of the nucleus accumbens: effects on classically conditioned responses and locomotor activity in the cat.
    Wilson WJ; Sołtysik SS
    Acta Neurobiol Exp (Wars); 1985; 45(3-4):91-105. PubMed ID: 2867668
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nucleus accumbens cholecystokinin (CCK) can either attenuate or potentiate amphetamine-induced locomotor activity: evidence for rostral-caudal differences in accumbens CCK function.
    Vaccarino FJ; Rankin J
    Behav Neurosci; 1989 Aug; 103(4):831-6. PubMed ID: 2765186
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Behavioral interaction between endogenous opioids, CCK-8 and dopaminergic systems in the nucleus accumbens of rats.
    van Ree JM; Igarashi J; Király I
    NIDA Res Monogr; 1986; 75():323-6. PubMed ID: 2448632
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The nucleus accumbens: is it an exclusive component of the dopaminergic system of the basal ganglia?].
    Herrera-Marschitz M; Ungerstedt U
    Neurologia; 1987; 2(2):47-9. PubMed ID: 3274069
    [No Abstract]   [Full Text] [Related]  

  • 9. [The role of the globus pallidus (GP) and nucleus accumbens (NAc) in the control of avoidance conditioning of rats].
    Mei ZT; Li DQ
    Sheng Li Xue Bao; 1987 Jun; 39(3):220-6. PubMed ID: 3672138
    [No Abstract]   [Full Text] [Related]  

  • 10. Cholecystokinin potentiates dopamine-mediated behaviors in the nucleus accumbens, a site of CCK-DA co-existence.
    Crawley JN
    Psychopharmacol Bull; 1985; 21(3):523-7. PubMed ID: 4034868
    [No Abstract]   [Full Text] [Related]  

  • 11. Intraaccumbens dopaminergic lesion suppresses desipramine effects in the forced swim test but not in the neuronal activity of lateral septal nucleus.
    Gutiérrez-García AG; Contreras CM; Díaz-Meza JL; Bernal-Morales B; Rodríguez-Landa JF; Saavedra M
    Prog Neuropsychopharmacol Biol Psychiatry; 2003 Aug; 27(5):809-18. PubMed ID: 12921914
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interaction of dopamine agonists with disrupted mesolimbic pathways implications for mental health.
    Wray SR; Melville GN; Wenger T; Louden D
    West Indian Med J; 1984 Jun; 33(2):106-16. PubMed ID: 6541399
    [No Abstract]   [Full Text] [Related]  

  • 13. Behavioral evidence for cholecystokinin modulation of dopamine in the mesolimbic pathway.
    Crawley JH
    Prog Clin Biol Res; 1985; 192():131-8. PubMed ID: 4080706
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Therapeutic value of the coexistence of cholecystokinin and dopamine. Electrophysiological studies in the rat].
    Debonnel G; de Montigny C
    Encephale; 1989; 15 Spec No():157-63. PubMed ID: 2743936
    [No Abstract]   [Full Text] [Related]  

  • 15. Substantia innominata: critical link in the behavioral expression of mesolimbic dopamine stimulation in the rat.
    Swerdlow NR; Swanson LW; Koob GF
    Neurosci Lett; 1984 Sep; 50(1-3):19-24. PubMed ID: 6493625
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mesolimbic dopamine and its control of locomotor activity in rats: differences in pharmacology and light/dark periodicity between the olfactory tubercle and the nucleus accumbens.
    Cools AR
    Psychopharmacology (Berl); 1986; 88(4):451-9. PubMed ID: 3085132
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Repeated treatment with imipramine and amitriptyline reduced the immobility of rats in the swimming test by enhancing dopamine mechanisms in the nucleus accumbens.
    Cervo L; Samanin R
    J Pharm Pharmacol; 1988 Feb; 40(2):155-6. PubMed ID: 2897457
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modulation of dopamine function by glycine in the nucleus accumbens of the brain of the rat.
    Barnes JC; Costall B; Naylor RJ
    Neuropharmacology; 1986 Dec; 25(12):1347-51. PubMed ID: 3561713
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Non-dopaminergic fibres may regulate dopamine-sensitive adenylate cyclase in the prefrontal cortex and nucleus accumbens.
    Tassin JP; Simon H; Hervé D; Blanc G; Le Moal M; Glowinski J; Bockaert J
    Nature; 1982 Feb; 295(5851):696-8. PubMed ID: 6276780
    [No Abstract]   [Full Text] [Related]  

  • 20. Behavioral abnormalities induced by frontal cortical and nucleus accumbens lesions.
    Starkstein SE; Moran TH; Bowersox JA; Robinson RG
    Brain Res; 1988 Nov; 473(1):74-80. PubMed ID: 3208127
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.